- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Xetra | 91,300 | 05.07.24 12:39:25 | -0,040 | -0,04% | 91,150 | 91,210 | 91,060 | 91,340 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 943,400 | 05.07.24 08:03:14 | -1,400 | -0,15% | 942,400 | 948,400 | 943,400 | 944,800 |
